Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2005
03/09/2005CN1589882A Medicine for treating rheumatoid anthritis and its preparation method
03/09/2005CN1589880A Traditional Chinese modicine for treating gynecopathy and its preparation method
03/09/2005CN1589877A Ready prepared Chinese medicine for treating angeitis and preparation process
03/09/2005CN1589870A Incised wound medicine
03/09/2005CN1589859A Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis
03/09/2005CN1589842A Mistura and its preparation method
03/09/2005CN1589841A Pain stopping powder agent and its preparation method
03/09/2005CN1589839A Stasis transforming pain relieving particle agent and its preparation method
03/09/2005CN1589837A Traditional Chinese medicine for treating spondylitis
03/09/2005CN1589829A Medicine for anticancer, anti-inflammation, calm panting
03/09/2005CN1589828A Compound saffron oil and its production technology
03/09/2005CN1589820A Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method
03/09/2005CN1589798A Suppository for treating cancer pain and its preparation method
03/09/2005CN1589788A Modulating multiple lineage kinase proteins
03/09/2005CN1589784A 5-hydroxymethyl -2-furol and its derivative analogue medical use
03/09/2005CN1192035C Inhibitors of interleukin-1'beta' converting enzyme
03/09/2005CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
03/09/2005CN1192027C Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/09/2005CN1192015C Cell adhesion inhibitors
03/09/2005CN1191861C Medicinal compositions containing anti-Fas antibody
03/09/2005CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit
03/09/2005CN1191826C Pharmaceutical formulation
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
03/08/2005US6864291 Agonists specific for the peripheral cannabinoid receptor
03/08/2005US6864288 Regulation of phospholipase D activity
03/08/2005US6864282 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
03/08/2005US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864261 Substituted piperzino-pyridine compound, useful for treting pain, anxiety, urinary incontinence, an addictive disorder, Parkinson's disease, epilepsy, psychosis, and used as Selective antagonists of the metabotropic glutamate receptor 5
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer
03/08/2005US6864243 Method for treating retinal degeneration with purinergic receptor agonists
03/08/2005CA2351848C Method for increasing pet activity
03/08/2005CA2100212C Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
03/03/2005WO2005019472A1 Method of detecting effect of controlling synoviolin activity
03/03/2005WO2005019456A1 Promoter of synoviolin gene
03/03/2005WO2005019245A1 Heptadepsin
03/03/2005WO2005019219A1 Pyrrolopyrimidinone derivative
03/03/2005WO2005019218A1 Pyrrolopyrimidinethione derivative
03/03/2005WO2005019182A1 Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
03/03/2005WO2005018675A1 Therapeutic agent for autoimmune disease
03/03/2005WO2005018649A1 Agent for inhibiting the formation of final saccharification product
03/03/2005WO2005018557A2 Substituted pyridinones
03/03/2005WO2005000298A3 5-membered heterocycle-based p-38 inhibitors
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005WO2003045317A3 Therapeutic protein and treatments
03/03/2005WO2003031405A3 Methods for the synthesis of substituted purines
03/03/2005US20050049312 N-(1-adamantyl)alkyl]alkano-amidines, guanidines or N'-nitroguanidines; non-competitive receptor antagonists for the NMDA receptor
03/03/2005US20050049303 Adamantane derivatives
03/03/2005US20050049294 Methods of using [3.2.0] heterocyclic compounds and analogs thereof
03/03/2005US20050049293 Increasing effect of released acetylcholine on hepatic muscarinic receptors
03/03/2005US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
03/03/2005US20050049288 5-MEMBERED HETEROCYCLE-BASED p38 KINASE INHIBITORS
03/03/2005US20050049283 Compounds that inhibit factor xa activity
03/03/2005US20050049263 Purine analogs having hsp90-inhibiting activity
03/03/2005US20050049259 Viricides; for the prophylaxis and treatment of herpes viral infections
03/03/2005US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease
03/03/2005US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors
03/03/2005US20050049251 Inhibitors of p38
03/03/2005US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine
03/03/2005US20050049241 Vanilloid receptor antagonists; acute or chronic pain, itching; inflammation; gastrointestinal and urinary tract disorders; tracheobronchial and diaphragmatic dysfunction
03/03/2005US20050049240 Tetrahydroisochinolines, their production and the use thereof as analgesics
03/03/2005US20050049234 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents
03/03/2005US20050049229 Antiinflammatory and/or antiplatelet aggregation actions; lower toxicity, reducing liver and/or kidney damage; analgesic and antipyretic activity
03/03/2005US20050049205 Product from rose hips e.g. 3- beta -D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO); arthritis and osteoarthritis
03/03/2005US20050049202 For treating disorders associated with excessive cytokine release such as interleukin-1 (IL-1) for example infection, cancer, asthma, coronary restenosis, autoimmune disease, cirrhosis, entotoxemia, reperfusion injury and septic shock; lactone or lactam-benzoates or benzamides
03/03/2005US20050049198 Contacting a cardiac ryanodine receptor (RyR2) with a fragment of a dihydropyridine receptor (DHPR) polypeptide; ischemic heart disease, congestive heart failure, cardiac hypertrophy (calcium overload), dysrhythmia, or heart attack, cardiomyopathy
03/03/2005US20050049189 Immunosuppressive protein for use in treatment and prevention of allergic, autoimmune, skin and respiratory disorders
03/03/2005US20050048639 Caspase-8 binding protein, its preparation and use
03/03/2005US20050048511 Truncated glycogen synthase kinase 3 protein for use in identifying modulators to treat diabetes, inflammation and nervous system disorders; drug screening
03/03/2005US20050048148 Synergistic mixtures; balancing (pro/anti)inflammatory cytokines
03/03/2005US20050048134 Therapy, prevention of papillomavirus infections; antiinflammatory agents; wound healing agents
03/03/2005US20050048132 Use of hydrochloric acid in the preparation of a medicament for the treatment of tumour
03/03/2005US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir
03/03/2005US20050048098 Semirigid eye implant; glycolic acid-lactic acid copolymer and release moderator for dexamethasome;
03/03/2005US20050048055 Use of CD40 engagement to alter T cell receptor usage
03/03/2005US20050048052 Bioassay for detecting expression of mammalian CC-chemokine receptor 2, by binding of antibody or antigen-binding fragment; human or humanized monoclonal antibody; test kits
03/03/2005US20050048045 Regulation of urokinase receptor expression by phosphoglycerate kinase
03/03/2005US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections
03/03/2005US20050048024 Compounds for use as surfactants
03/03/2005CA2536495A1 Promoter of synoviolin gene
03/03/2005CA2536071A1 Methods for detecting regulatory effect on synoviolin activity
03/03/2005CA2523658A1 Rnai agents for anti-sars coronavirus therapy
03/02/2005EP1510519A1 Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives
03/02/2005EP1510518A2 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels
03/02/2005EP1510516A1 Pyrazole compound and medicinal composition containing the same
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1510217A1 An anti-rheumatism medicament and method to prepare thereof
03/02/2005EP1510210A1 Immunity-related protein kinase inhibitors
03/02/2005EP1509621A1 Treatment with cytokines for alzheimer's disease
03/02/2005EP1509618A2 Autoimmune conditions and nadph oxidase defects
03/02/2005EP1509617A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
03/02/2005EP1509532A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509530A1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof
03/02/2005EP1509523A2 Triazaspiro compounds useful for treating or preventing pain
03/02/2005EP1509515A2 Substituted 4-aryl-4h-pyrrolo 2,3-h chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
1 ... 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 ... 1272